Megagly 4mg (Glimepiride)
Glimepiride 4mg
Tablet · Prescription medication
LNC Bio Co., Ltd.
MFDS item code 202002589 · Approved 2020.04.13
This product's status changed to Approval withdrawn on 2024.09.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used to assist dietary and exercise therapy to improve blood sugar control in patients with type 2 diabetes. It can be administered alone, and if blood sugar control is insufficient, it can be combined with insulin or other oral hypoglycemic agents. For example, if blood sugar control is difficult with sulfonylurea or metformin monotherapy, this medication can be taken additionally to help with blood sugar control. This effectively manages the patient's blood sugar levels and contributes to the prevention of complications.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is taken orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, doses above 4 mg provide little additional benefit, but some patients have shown better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider using insulin or another oral antidiabetic agent in combination. 2) Subsequent dose adjustment As diabetes control improves during treatment, the amount of this medicine required may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering agent to this medicine There is no precise dose equivalence between this medicine and other oral glucose-lowering agents. When switching to this medicine from another oral glucose-lowering agent, it is recommended to follow the approach described under Initial dose. That is, initiate treatment at 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medication should be taken into account. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately taking sugar. Hypoglycemia may recur despite successful initial management when sulfonylureas are administered. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure when fasting blood glucose (FBG) is above 150 mg/dL. This medicine is administered at 8 mg once daily with the first meal, while insulin is initiated at a low dose and increased approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical data are available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered in combination with metformin, and the risk may increase. Appropriate caution should be exercised.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or coma. Patients with allergies to this drug or its ingredients, as well as to sulfonylureas or sulfonamide drugs, should also not take this medication. There is no experience with its use in patients with severe impairment of liver or kidney function, and it is recommended to switch to insulin therapy in such cases. Women who are pregnant or may become pregnant, as well as those who are breastfeeding, should not take this medication. Patients with severe infections, or those undergoing surgery or severe trauma, should also receive insulin therapy. Care should be taken in cases of gastrointestinal disorders, such as diarrhea or vomiting, as food absorption may not be adequate, leading to hypoglycemia. This medication contains lactose, so it should not be taken by patients with lactose intolerance or specific genetic metabolic disorders. During the first week of treatment, there is a high risk of hypoglycemia, so careful monitoring is required. Patients who are malnourished or skip meals, as well as those with irregular eating habits, are at a greater risk of hypoglycemia. Caution should also be exercised when there is an imbalance between exercise and carbohydrate intake or if meal patterns change. Those who frequently consume alcohol or particularly skip meals are at a higher risk of hypoglycemia and should be more vigilant. Hypoglycemia can easily occur in patients with decreased kidney or liver function or in cases of overdose with this medication. Additionally, endocrine disorders such as thyroid dysfunction, pituitary dysfunction, or adrenal insufficiency can influence blood sugar control. Elderly patients or those taking other medications also have an increased risk of hypoglycemia and should be managed carefully with consultation from a doctor. This medication can cause hypoglycemia due to its blood sugar-lowering effect. Symptoms of hypoglycemia can include headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, loss of consciousness, etc. Blurred vision, gastrointestinal disorders, abdominal pain, and diarrhea may also occur. Changes in liver function, alterations in blood cell counts, and allergic reactions can occur rarely, so any abnormal symptoms should be reported to healthcare personnel immediately. Severe hypoglycemia or allergic reactions can be life-threatening, requiring urgent treatment. This medication should be taken regularly, and optimal blood sugar control is possible when combined with dietary and exercise therapy. If hypoglycemia occurs, quick intake of sugar is necessary to relieve symptoms, and it is advisable to always carry sugary drinks or foods. During the initial treatment period, hypoglycemic symptoms should be closely monitored, and consultation with a doctor should occur in the event of other illnesses or lifestyle changes. Special caution is required when operating vehicles or machinery while taking this medication. This medication can interact with other drugs; therefore, if other medications are being taken, it is essential to inform the healthcare provider. Particularly, concurrent use with certain antibiotics, antifungals, antihypertensives, anticoagulants, and beta-blockers can affect blood sugar control. Beta-blockers and similar drugs may mask some symptoms of hypoglycemia, so additional caution is warranted. It is safe for pregnant or breastfeeding women to avoid this medication, and insulin therapy may be recommended if necessary. Particularly for breastfeeding women, care should be taken to prevent the baby from ingesting the medication. Safety and efficacy in children under 18 years of age have not been established, so use is not recommended. Elderly patients may have decreased kidney function, so the dosage of this medication should be adjusted carefully. In the event of an overdose of this medication, hypoglycemia may occur, requiring immediate emergency treatment. Inducing vomiting or administering activated charcoal and laxatives may be necessary, and in severe cases, intravenous glucose should be administered to maintain normal blood sugar levels.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage helps maintain the medication's effectiveness and safety.
Light blue oblong tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Glimepiride 4mg
Tablet · Prescription medication
LNC Bio Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.